KLKelly Larson

Kelly Larson

*This is an algorithmically generated author record based on publicly available information.

Kelly Larson has a total of 26 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Maternal Health Outcomes Associated With Syphilis Infection During Pregnancy: Evidence From a Large US All-Payer Hospital-Centered Administrative Database

    by Abayomi Walker, Deborah Kilday, Michael Korvink, Sydney Westfall, Drew Tatum, Richelle Marshall, Ashley Finke, Stephanie Martin, Raymond Perigard, Kathy W Belk, et al.

    Background: Syphilis during pregnancy is associated with preventable maternal and infant harms. As syphilis rates rise in the United States, recent, nationally representative data on maternal outcomes remain limited. Methods: A retrospective cohort study was conducted using a large all-payer administrative database to assess the prevalence of maternal syphilis, variation in screening, testing, treatment, and associations with maternal outcomes and healthcare utilization. The study included inpatient delivery hospitalizations at 20 or more weeks of gestation discharged 1 October 2019, to 31 December 2023, with 365-day look-back and 90-day follow-up periods. The cohort comprised 3 639 838 deliveries, including 5533 documented with maternal syphilis. Outcomes included hypertensive disorders of pregnancy, severe maternal morbidity (SMM), length of stay, hospital costs, and hospital returns. Results: Syphilis prevalence was 152 per 100 000 deliveries with escalation throughout the study period. Rates were higher among younger, American Indian/Alaska Native and Black, and Medicaid-covered patients. Documented nontreponemal screening and treponemal testing were observed for 29% and 30% of deliveries, respectively. Among deliveries with syphilis, 22% had documented administration of penicillin. After adjustment for maternal and hospital characteristics, syphilis was associated with higher adjusted odds ratio (aOR) of hypertensive disorders (aOR 1.18), 90-day returns (aOR 1.39), SMM including transfusion (aOR 1.23), longer delivery stays (adjusted rate ratio1.09), and higher in-hospital costs (adjusted cost ratio 1.08). Conclusions: Maternal syphilis prevalence increased and was associated with greater maternal morbidity, resource utilization, and costs. Variation in documented screening, testing, and treatment frequencies highlights potential opportunities to improve implementation of recommended care.

  • Open Access

    Association between COVID-19 by variant period and delivery-related outcomes in the United States

    by Deborah Kilday, Michael Korvink, Drew Tatum, Zhun Cao, Ning Rosenthal, Raymond Perigard, Ashley Finke, Richelle Marshall, Margaret Snyder, Kelly Larson, et al.

    Background: COVID-19 has been associated with adverse obstetric outcomes, but the magnitude of maternal and fetal risk may have varied across viral variant periods. Objective: To assess the association between COVID-19 infection and delivery-related in-hospital and 90-day mortality, severe maternal morbidity (SMM), fetal outcomes (fetal death and preterm birth), and a set of utilization measures (including cesarean delivery, ICU admission, costs, and hospital length of stay [LOS]) in the United States. Methods: A retrospective cohort study was conducted using delivery-related hospitalizations discharged between April 1, 2020, and March 31, 2023, from the Premier Healthcare Database. Regression modeling was conducted to evaluate variant-period-specific associations between COVID-19 exposure and key outcomes while controlling for a broad set of maternal risk factors. Results: Of the 2,561,615 evaluated delivery-related discharges, 53,226 (2.08%) were diagnosed with COVID-19. COVID-19 was associated with higher adjusted odds of in-hospital mortality across the Pre-Alpha, Alpha, Delta, and first Omicron phases (aOR [p-adj]: 13.11 [<.001], 13.03 [<.001], 29.47 [<.001], and 3.55 [.04]), respectively. Maternal COVID-19 infection was further associated with increased odds of fetal death at 20 or more weeks of gestation across the Pre-Alpha (aOR: 1.53 [1.28–1.83, < .001]) and Delta (3.37 [2.95–3.84, < .001]) phases. The odds of experiencing any SMM, ICU admission, or preterm birth were significantly higher across all phases of the pandemic, whereas the odds of cesarean delivery were significantly higher during all but the Alpha and first Omicron phases. COVID-19 infection was associated with increased LOS and hospital costs throughout all variant phases. Conclusions: COVID-19 infection during delivery was associated with higher odds of maternal, fetal, and utilization outcomes at varying stages of the pandemic, with the most notable effect during the Delta period. These findings provide insight into the variant-dependent obstetric burden of COVID-19 and for maternal health surveillance and clinical preparedness during future infectious disease outbreaks.